Imaging Biometrics: IQ-AI says Imaging Biometrics submits paediatric rare disease request

(marketscreener.com) IQ-AI Ltd on Wednesday said its wholly-owned subsidiary Imaging Biometrics LLC has submitted a paediatric rare disease request to the US Food & Drug Administration for its gallium maltolate therapy. The St Helier, Jersey-based medical services firm focused on cancer treatment said the request is for gallium maltolate as an oral treatment for...https://www.marketscreener.com/quote/stock/ELM-COMPANY-133509697/news/IQ-AI-says-Imaging-Biometrics-submits-paediatric-rare-disease-request-45271514/?utm_medium=RSS&utm_content=20231108